Reply to ‘Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease’

Competing interests

B.B. reports that he was a consulting expert, on behalf of the plaintiff, for litigation related to two specific brand models of inferior vena cava (IVC) filters. B.B. has not been involved in the litigation in 2022–2024 nor has he received any compensation in 2022–2024. B.B. reports that he is a member of the Medical Advisory Board for the North American Thrombosis Forum and serves in the Data Safety and Monitory Board of the NAIL-IT trial funded by the National Heart, Lung, and Blood Institute, and Translational Sciences. B.B. is a collaborating consultant with the International Consulting Associates and the US Food and Drug Administration in a study to generate knowledge about utilization, predictors, retrieval and safety of IVC filters. Unrelated to this article, B.B. is supported by a Career Development Award from the American Heart Association and VIVA Physicians (#938814). A.H.T. declares no competing interests.

留言 (0)

沒有登入
gif